loading
Schlusskurs vom Vortag:
$7.10
Offen:
$7.09
24-Stunden-Volumen:
10,232
Relative Volume:
0.06
Marktkapitalisierung:
$269.36M
Einnahmen:
$128.45M
Nettoeinkommen (Verlust:
$6.54M
KGV:
143.80
EPS:
0.05
Netto-Cashflow:
$-8.79M
1W Leistung:
+6.05%
1M Leistung:
-2.31%
6M Leistung:
+6.36%
1J Leistung:
+26.58%
1-Tages-Spanne:
Value
$6.97
$7.20
1-Wochen-Bereich:
Value
$6.61
$7.37
52-Wochen-Spanne:
Value
$4.76
$8.85

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Name
Firmenname
Lifecore Biomedical Inc
Name
Telefon
(952) 368-4300
Name
Adresse
3515 LYMAN BOULEVARD, CHASKA
Name
Mitarbeiter
406
Name
Twitter
Name
Nächster Verdiensttermin
2025-10-27
Name
Neueste SEC-Einreichungen
Name
LFCR's Discussions on Twitter

Vergleichen Sie LFCR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
LFCR
Lifecore Biomedical Inc
7.195 266.01M 128.45M 6.54M -8.79M 0.05
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
143.18 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.46 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.205 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.14 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
449.15 19.53B 3.08B 1.24B 1.07B 25.61

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-04 Eingeleitet KeyBanc Capital Markets Sector Weight
2025-05-21 Eingeleitet William Blair Outperform
2024-09-05 Eingeleitet Craig Hallum Buy
2024-08-28 Herabstufung Barrington Research Outperform → Mkt Perform
2023-03-20 Herabstufung Stephens Overweight → Equal-Weight

Lifecore Biomedical Inc Aktie (LFCR) Neueste Nachrichten

pulisher
06:01 AM

Why millennials buy Lifecore Biomedical Inc. (LDE) stockJuly 2025 Fed Impact & Consistent Profit Trading Strategies - newser.com

06:01 AM
pulisher
03:53 AM

Is Lifecore Biomedical Inc. (LDE) stock suitable for passive index fundsJuly 2025 Selloffs & Technical Entry and Exit Alerts - newser.com

03:53 AM
pulisher
01:39 AM

Will Lifecore Biomedical Inc. (LDE) stock gain from lower interest ratesJuly 2025 Fed Impact & Community Shared Stock Ideas - newser.com

01:39 AM
pulisher
01:24 AM

Is Lifecore Biomedical Inc. forming a reversal patternJuly 2025 Analyst Calls & Real-Time Stock Price Movement Reports - newser.com

01:24 AM
pulisher
01:21 AM

What catalysts could drive Lifecore Biomedical Inc. stock higher2025 Trading Volume Trends & Fast Moving Market Watchlists - newser.com

01:21 AM
pulisher
01:04 AM

Is Lifecore Biomedical Inc. (LDE) stock undervalued after correctionMarket Performance Recap & Real-Time Volume Surge Alerts - newser.com

01:04 AM
pulisher
12:58 PM

Can Lifecore Biomedical Inc. stock weather global recessionGlobal Markets & Expert Approved Trade Ideas - newser.com

12:58 PM
pulisher
Oct 30, 2025

Is Lifecore Biomedical Inc. stock affected by interest rate hikesIndex Update & Weekly Breakout Stock Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025 - The Manila Times

Oct 30, 2025
pulisher
Oct 30, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect - ACCESS Newswire

Oct 30, 2025
pulisher
Oct 30, 2025

Here’s Why Lifecore Biomedical Inc (LFCR) Declined 22% at the End of Q3 - Insider Monkey

Oct 30, 2025
pulisher
Oct 30, 2025

Will Lifecore Biomedical Inc. outperform the marketPrice Action & Precise Trade Entry Recommendations - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Key metrics from Lifecore Biomedical Inc.’s quarterly data2025 Top Gainers & Community Verified Trade Signals - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Can Lifecore Biomedical Inc. stock beat market expectations this quarterWeekly Market Summary & Safe Capital Allocation Plans - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Can Lifecore Biomedical Inc. stock surprise with earnings upsidePortfolio Risk Summary & Risk Controlled Daily Trade Plans - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

What hedge fund moves indicate for Lifecore Biomedical Inc. (LDE) stock2025 EndofYear Setup & Fast Momentum Entry Tips - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Will Lifecore Biomedical Inc. (LDE) stock benefit from infrastructure billGold Moves & Short-Term Swing Trade Alerts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Is it too late to sell Lifecore Biomedical Inc.Quarterly Profit Review & Safe Entry Trade Reports - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Lifecore signs agreement with leading global pharmaceutical company - TipRanks

Oct 29, 2025
pulisher
Oct 29, 2025

Lifecore Selected as Commercial Mfg. Partner for Leading Injectable Product - Contract Pharma

Oct 29, 2025
pulisher
Oct 29, 2025

Lifecore Biomedical Selects as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

What analysts say about Lifecore Biomedical Inc stockTrend Following Strategies & Outstanding Growth Portfolio - earlytimes.in

Oct 29, 2025
pulisher
Oct 29, 2025

Lifecore (NASDAQ: LFCR) to transfer manufacturing; second agreement with same multinational - Stock Titan

Oct 29, 2025
pulisher
Oct 29, 2025

Lifecore and PolyPeptide link for US peptide manufacturing - Yahoo Finance

Oct 29, 2025
pulisher
Oct 29, 2025

Will Lifecore Biomedical Inc. (LDE) stock see insider accumulationJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Real time pattern detection on Lifecore Biomedical Inc. stockGap Down & Free High Accuracy Swing Entry Alerts - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Lifecore, PolyPeptide Partner on Peptide Manufacturing Solution for U.S. Market - Contract Pharma

Oct 28, 2025
pulisher
Oct 28, 2025

What sentiment indicators say about Lifecore Biomedical Inc. stockWeekly Investment Report & Smart Investment Allocation Insights - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Lifecore, PolyPeptide collab to offer peptide manufacturing solution - TipRanks

Oct 28, 2025
pulisher
Oct 28, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Connect - ACCESS Newswire

Oct 28, 2025
pulisher
Oct 28, 2025

Lifecore, PolyPeptide Partner on Peptide Manufacturing for U.S. Market - Contract Pharma

Oct 28, 2025
pulisher
Oct 28, 2025

Lifecore Biomedical, Inc. and Polypeptide Laboratories, Inc. Announce Collaboration Intended to Offer End-To-End Peptide Manufacturing Solution for U.S. Market - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

Lifecore and PolyPeptide partner on integrated peptide manufacturing By Investing.com - Investing.com Nigeria

Oct 28, 2025
pulisher
Oct 28, 2025

Lifecore and PolyPeptide partner on integrated peptide manufacturing - Investing.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will Lifecore Biomedical Inc. (LDE) stock recover faster than industry2025 Trading Recap & Scalable Portfolio Growth Methods - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market - The Manila Times

Oct 28, 2025
pulisher
Oct 28, 2025

Lifecore Biomedical and PolyPeptide Laboratories Announce Collaboration to Enhance Peptide-Based Pharmaceutical Development - Quiver Quantitative

Oct 28, 2025
pulisher
Oct 28, 2025

Lifecore (NASDAQ: LFCR), PolyPeptide sign U.S. DS-to-DP peptide collaboration - Stock Titan

Oct 28, 2025
pulisher
Oct 28, 2025

Why pension funds invest in Lifecore Biomedical Inc. (LDE) stockJuly 2025 Retail & Verified Momentum Watchlists - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will Lifecore Biomedical Inc. stock rally after Fed decisionsWeekly Profit Report & Risk Controlled Swing Alerts - Fundação Cultural do Pará

Oct 28, 2025

Finanzdaten der Lifecore Biomedical Inc-Aktie (LFCR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$46.22
price up icon 4.84%
drug_manufacturers_specialty_generic RDY
$13.31
price down icon 1.04%
$22.65
price up icon 0.39%
$10.39
price up icon 0.39%
$139.69
price up icon 1.05%
$449.15
price down icon 1.27%
Kapitalisierung:     |  Volumen (24h):